Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Related Citations for PubMed (Select 17523723)

1.

Carboplatin in Combination with Bendamustine in Previously Untreated Patients with Extensive-Stage Small Cell Lung Cancer (SCLC).

Köster W, Stamatis G, Heider A, Avramidis K, Wilke H, Koch JA, Stahl M.

Clin Drug Investig. 2004;24(10):611-8.

PMID:
17523723
2.

A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer.

Inoue A, Yamazaki K, Maemondo M, Suzuki T, Kimura Y, Kanbe M, Isobe H, Nishimura M, Saijo Y, Nukiwa T.

J Thorac Oncol. 2006 Jul;1(6):551-5.

PMID:
17409916
3.

Phase II trial with carboplatin and bendamustine in patients with extensive stage small-cell lung cancer.

Köster W, Heider A, Niederle N, Wilke H, Stamatis G, Fischer JR, Koch JA, Stahl M.

J Thorac Oncol. 2007 Apr;2(4):312-6.

PMID:
17409803
4.

Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer.

Mauer AM, Ansari RH, Hoffman PC, Krauss SA, Taber D, Tembe SA, Gabrys GT, Cotter T, Schumm LP, Szeto L, Vokes EE.

Ann Oncol. 2003 May;14(5):722-8.

5.

A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.

Fukuda M, Nakamura Y, Kasai T, Nagashima S, Nakatomi K, Doi S, Nakano H, Takatani H, Fukuda M, Kinoshita A, Soda H, Tsukamoto K, Oka M, Kohno S; Nagasaki Thoracic Oncology Group.

J Thorac Oncol. 2009 Jun;4(6):741-5. doi: 10.1097/JTO.0b013e3181a52946.

PMID:
19404211
6.

A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer.

Okamoto H, Naoki K, Narita Y, Hida N, Kunikane H, Watanabe K.

Lung Cancer. 2006 Aug;53(2):197-203. Epub 2006 Jun 15.

PMID:
16781005
7.

A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer.

Garst J, Herndon JE 2nd, Shafman T, Campagna L, Blackwell S, Padilla K, Bjurstrom T, Andrews C, Maravich-May D, Anderson E, Crawford J.

Clin Drug Investig. 2006;26(5):257-66.

PMID:
17163259
8.

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.

Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.

Gynecol Oncol. 2005 Jan;96(1):168-72.

PMID:
15589596
9.

Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer.

Socinski MA, Sandler AB, Miller LL, Locker PK, Hanover CK, Elfring GL, Israel VK, Pirotta N, Natale RB.

J Clin Oncol. 2001 Feb 15;19(4):1078-87.

PMID:
11181672
10.

Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancer.

Fidias P, Pennell NA, Boral AL, Shapiro GI, Skarin AT, Eder JP Jr, Kwoh TJ, Geary RS, Johnson BE, Lynch TJ, Supko JG.

J Thorac Oncol. 2009 Sep;4(9):1156-62. doi: 10.1097/JTO.0b013e3181b2793f.

PMID:
19704336
11.
13.

Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.

Masters GA, Hahn EA, Shevrin DH, Kies MS.

Lung Cancer. 2003 Feb;39(2):221-6.

PMID:
12581577
14.

A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.

Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):515-22.

15.

Phase I study of concurrent real-time tumor-tracking thoracic radiation therapy with paclitaxel and carboplatin in locally advanced non-small cell lung cancer.

Sakakibara-Konishi J, Oizumi S, Kinoshita I, Shinagawa N, Kikuchi J, Kato M, Inoue T, Katoh N, Onimaru R, Shirato H, Dosaka-Akita H, Nishimura M.

Lung Cancer. 2011 Nov;74(2):248-52. doi: 10.1016/j.lungcan.2011.02.009. Epub 2011 Mar 12.

PMID:
21397973
16.
17.
18.

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.

Hainsworth JD, Gray JR, Stroup SL, Kalman LA, Patten JE, Hopkins LG, Thomas M, Greco FA.

J Clin Oncol. 1997 Dec;15(12):3464-70.

PMID:
9396399
19.

A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.

Gillenwater HH, McCune JS, Lindley C, Faucette S, Shord S, Donahue A, Socinski MA, Stewart CF, Zamboni WC, Kirstein MN, Moore D.

Cancer Invest. 2005;23(6):511-9.

PMID:
16203659
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk